AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MEDICA GROUP PLC

Director's Dealing Jun 11, 2020

4972_dirs_2020-06-11_b21acda5-14db-4fcc-8ee4-d73a30cfcc83.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 7168P

Medica Group PLC

11 June 2020

Medica Group PLC

Director / PDMR Shareholding

Medica Group PLC (the "Company") announces that on 11 June 2020, a connected person to the PDMR listed below purchased ordinary shares of 0.2p each ("Ordinary Shares") at a price of 130.8p in the Company.

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation and set out more details of the transactions.

1

Details of the person discharging managerial responsibility

a)

Name

Max Neal Easton

2

Reason for the notification

a)

Position/status

Connected person to Joanne Easton, Non Executive Director

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Medica Group PLC

b)

Legal Entity Identifier Code

213800B8XE5FUSZF5Z16

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 0.2p each in the capital of the Company ("Shares")

b)

Identification Code

GB00BYV24996

c)

Nature of the transaction

Acquisition of Ordinary Shares

d)

Currency

GBP- British Pound

e)

Price(s) and Volume(s)

Price(s) per share Volume(s)
130.8 1512

f)

Aggregated Information

-  Price

-  Volume

-  Total Price

Price(s) per share Volume(s) Total Aggregate Price
130.8 1512 £ 1,999.54

g)

Date of transaction

11 June 2020

h)

Place of transaction

London Stock Exchange, Main Market (XLON)

-ENDS-

For further details contact:

Medica Group: +44 (0)33 33 111 222
Stuart Quin, Chief Executive Officer
FTI Consulting +44 (0)20 3727 1000
Victoria Foster Mitchell / Robert Winder

About Medica

Medica is the UK market leader by revenue in the provision of teleradiology services, providing outsourced interpretation and reporting on MRI (magnetic resonance imaging), CT (computerised tomography) and plain film (x-ray) images. The Company currently offers three primary services to hospital radiology departments: NightHawk, an out-of-hours service, routine cross-sectional (Routine CS) reporting on MRI and CT scans, and routine plain film (Routine PF) reporting on x-ray images.

Medica has developed a bespoke secure IT platform that provides market-leading linkage between a hospital's Radiology Information System (RIS) and Consultant Radiologists who contract with Medica. Direct RIS access ensures that the full wider patient information is available and reviewed with every report. 

The Company contracts with the largest pool of consultant radiologists outside of the NHS and has been trusted to provide more than 1.5 million examinations annually across its customer base of more than 100 NHS hospitals and various private hospital groups and diagnostic imaging companies. For more information please visit www.medicagroup.co.uk 

About teleradiology

Teleradiology is the electronic transmission of radiological patient images, including plain film (x-rays), CT scans and MRI scans, from one location to another for the purposes of diagnostic interpretation and reporting.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHKKDBDQBKDFAD

Talk to a Data Expert

Have a question? We'll get back to you promptly.